全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 150629-67-7 | N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]-L-lysine;Fmoc-L-Lys(Dde)-OH | C31H36N2O6 |
| 150668-81-8 | 3-Isopropyl-4-piperidone | C8H15NO |
| 150668-82-9 | 3,3-Dimethylpiperidine-4-one;3,3-Dimethyl-4-piperidone | C7H13NO |
| 150683-30-0 | Tolvaptan;N-[4-[(5R)-7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]-3-methylphenyl]-2-methylbenzamide | C26H25ClN2O3 |
| 150691-04-6 | 2-(tert-Butylamino)sulfonylphenylboronic acid | C10H16BNO4S |
| 150698-72-9 | 1-(6-Chloropyridin-3-yl)-2,2,2-trifluoroethanone | C7H3ClF3NO |
| 150710-72-8 | Calyxamine B;1-(2,2,6,6-Tetramethyl-4-piperidinylidene)-2-propanone | C12H21NO |
| 150712-24-6 | 5-Benzyl-1H-pyrazol-3-amine;5-Benzyl-2H-pyrazol-3-amine | C10H11N3 |
| 150725-87-4 | 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)-4-pyrimidinyl]benzenesulfonamide;Ro 46-2005 | C23H27N3O6S |
| 150726-89-9 | Dimethyl 2-(2-methoxyphenoxy)malonate;2-(2-Methoxyphenoxy)malonic acid dimethyl ester | C12H14O6 |
| 150727-06-3 | 4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide;N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide | C25H26ClN5O4S |
| 150728-12-4 | 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione | C15H12N4O4 |
| 150728-13-5 | 4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine;Bosentan Related Compound 1 | C15H10Cl2N4O2 |
| 150736-72-4 | N-Boc-(S)-(-)-2-amino-1-butanol | C9H19NO3 |
| 150760-95-5 | Cyanomethyl formate;(Formyloxy)acetonitrile | C3H3NO2 |
| 150763-13-6 | [4'-Ethyl-1,1'-bicyclohexyl]-4-one | C14H24O |
| 150763-46-5 | trans-4'-Ethyl-[1,1'-bicyclohexyl]-4-one;4-(trans-4-Ethylcyclohexyl)cyclohexanone | C14H24O |
| 150780-40-8 | 6-Bromo-2-trifluoromethylimidazo[1,2-a]pyridine | C8H4BrF3N2 |
| 150780-67-9 | 5'-O-(4,4-Dimethoxytrityl)-2'-O-methyl-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite;5'-O-DMT-2'-O-Me-rG(N-iBu)-3'-CEDPA | C45H56N7O9P |
| 150798-78-0 | 4-[2-(Dimethylamino)ethoxy]benzoic acid | C11H15NO3 |
| 150810-68-7 | 5-Carboxytetramethylrhodamine succinimidyl ester;5-TAMRASE | C29H25N3O7 |
| 150810-69-8 | 6-Carboxytetramethylrhodamine succinimidyl ester;6-TAMRASE | C29H25N3O7 |
| 150812-12-7 | Retigabine;2-Amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzene | C16H18FN3O2 |
| 150812-21-8 | 2-Amino-5-[(4-fluorobenzyl)amino]-1-nitrobenzene | C13H12FN3O2 |
| 150812-32-1 | 2-Amino-4-bromo-5-chlorobenzoic acid;4-Bromo-5-chloroanthranilic acid | C7H5BrClNO2 |
| 150821-03-7 | Pranlukast hemihydrate;N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-benzamide hemihydrate; Pranlukast hydrate | 2(C27H23N5O4).H2O |
| 150824-47-8 | Nitenpyram;(E)-N-[(6-Chloropyridin-3-yl)methyl]-N-ethyl-N'-methyl-2-nitroethene-1,1-diamine | C11H15ClN4O2 |
| 150828-96-9 | N-Boc-N'-Fmoc-L-ornithine;Boc-Orn(Fmoc)-OH | C25H30N2O6 |
| 150849-52-8 | (2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium sodium salt | C19H12IN5NaO8S2 |
| 150878-36-7 | 6-Chloro-4-cyclopropyl-2(1H)-quinazolinone | C11H9ClN2O |
| 150915-40-5 | Tirofiban hydrochloride monohydrate;N-(Butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-L-tyrosine monohydrochloride monohydrate; (2S)-2-(Butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propanoic acid hydrochloride hydrate | C22H36N2O5S.HCl.H2O |
| 150935-62-9 | 3-Bromo-6-methyl-5-nitro-2-pyridinamine | C6H6BrN3O2 |
| 150939-76-7 | Bis(2,2,6,6-tetramethylheptan-3,5-dionato)(tetraglyme)strontium | C32H60O9Sr |
| 150956-92-6 | 1-(2,4-Dinitrophenyl)-L-prolyl-3-cyclohexyl-L-alanylglycyl-S-methyl-L-cysteinyl-L-histidyl-L-alanyl-N6-[2-(methylamino)benzoyl]-L-lysinamide | C49H68N14O12S |
| 150969-56-5 | 5-(Trifluoromethyl)-1-indanone | C10H7F3O |
| 150986-62-2 | (3R,4R)-1-(tert-Butoxycarbonyl)-3,4-dihydroxypyrrolidine | C9H17NO4 |
| 151004-88-5 | (R)-N-Cbz-3,4-Dihydro-1H-isoquinolinecarboxylic acid | C18H17NO4 |
| 151004-92-1 | (S)-1,2,3,4-Tetrahydroisoquinoline-1-carboxylic acid | C10H11NO2 |
| 151004-93-2 | (R)-1,2,3,4-Tetrahydro-1-isoquinolinecarboxylic acid | C10H11NO2 |
| 151004-94-3 | (S)-3,4-Dihydro-1,2(1H)-isoquinolinedicarboxylic acid 2-(1,1-dimethylethyl) ester | C15H19NO4 |
| 151004-96-5 | (R)-2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid | C15H19NO4 |
| 151012-17-8 | N6-[[(2-Chlorophenyl)methoxy]carbonyl]-N2-[(1,1-dimethylethoxy)carbonyl]-N2-methyl-L-lysine | C20H29ClN2O6 |
| 151012-31-6 | 1-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-methanol;2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole | C15H18BrClN2O |
| 151038-94-7 | epsilon-Maleimidocaproyl hydrazide mono(trifluoroacetate) | C10H15N3O3.C2HF3O2 |
| 151038-96-9 | INNO-206;DOXO-EMCH; Doxorubicin-EMCH; N'-[(1E)-1-{4-[(3-Amino-2,3,6-trideoxyhexopyranosyl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-2-tetracenyl}-2-hydroxyethylidene]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexane hydrazide | C37H42N4O13 |
| 151049-87-5 | 3-Bromo-1-methyl-1H-pyrazole;3-Bromo-1-methylpyrazole | C4H5BrN2 |
| 151059-43-7 | 2-Phenylethylamine Hydroiodide;2-phenylethan-1-amine hydroiodide | C8H12IN |
| 151061-28-8 | Pravastatin EP Impurity F;(3R,5R)-7-((1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid Sodium Salt | C18H28O6 .Na |
| 151062-55-4 | 2-Methyl-D-cysteine hydrochloride | C4H9NO2S.HCl |
| 151077-62-2 | 2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide | C16H13F3N4O3 |